Now showing items 1-2 of 2

    • Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. 

      Baeten, JM; Donnell, D; Ndase, P; Mugo, NR; Campbell, JD; Wangisi, J; Tappero, JW; Bukusi, EA; Cohen, CR; Katabira, E; Ronald, A; Tumwesigye, E; Were, E; Fife, KH; Kiarie, J; Farquhar, C; John-Stewart, G; Kakia, A; Odoyo, J; Mucunguzi, A; Nakku-Joloba, E; Twesigye, R; Ngure, K; Apaka, C; Tamooh, H; Gabona, F; Mujugira, A; Panteleeff, D; Thomas, KK; Kidoguchi, L; Krows M, Revall J; Morrison S, Haugen H; Emmanuel-Ogier, M; Ondrejcek L, Frenkel L, Hendrix C Coombs RW,; Bumpus NN, Haberer JE, Stevens WS Bangsberg D,; Lingappa JR, Celum C (Global Health, University of Washington, Seattle, WA 98104, USA, 2012)
      BACKGROUND: Antiretroviral preexposure prophylaxis is a promising approach for preventing human immunodeficiency virus type 1 (HIV-1) infection in heterosexual populations. METHODS: We conducted a randomized trial ...
    • Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial. 

      Baeten, JM; Donnell, D; Mugo, NR; Ndase, P; Thomas, K; Campbell, J; Wangisi, J; Tappero, JW; Bukusi, EA; Cohen, CR; Katabira, E; Ronald, A; Tumwesigye, E; Were, E; Fife, KH; Kiarie, J; Farquhar, C; John-Stewart, G; Kidoguchi, L; Coombs, RW; Hendrix, C; Marzinke, MA; Frenkel, L; Haberer, JE; Bangsberg, D; Celum, C (2014)
      Abstract BACKGROUND: Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious ...